Myomo, Inc. is a wearable medical robotics company that offers improved arm and hand function for those suffering from neurological disorders and upper-limb paralysis. It develops and markets the MyoPro product line. MyoPro is a powered upper-limb orthosis designed to support the arm and restore function to the weakened or paralyzed arms of certain patients suffering from CVA stroke, brachial plexus injury, traumatic brain or spinal cord injury, ALS or other neuromuscular disease or injury. MyoPro senses a patient’s own electromyography (EMG) signals through non-invasive sensors on the arm, and can restore an individual’s ability to perform activities of daily living, including feeding themselves, carrying objects and doing household tasks. It provides devices directly to patients and bill their insurance companies directly. It also sells its products through various other sales channels, including through orthotics and prosthetics providers, the veteran’s administration, and others.
高成長
同社の収益は過去3年間にわたり着実に増加しており、年平均で109.26%の成長率を示しています。
成長中
同社は成長フェーズにあり、最新の年間収益はUSD 32.55Mに達しています。
適正水準
同社の最新のPEは-3.87で、過去3年間の水準と比較して適正圏にあります。
機関投資家の買い増し
最新の機関投資家の保有株数は25.59M株で、前四半期比で5.25%増加しています。
市場活動が活発
同社への投資家の関心が高まっており、20日間の売買回転率は2.52です。